Skip to main navigation Skip to search Skip to main content

AI virtual cells for drug discovery and pharmacology

  • Macao Polytechnic University
  • Chinese Academy of Medical Sciences
  • National University of Singapore
  • Chengdu University of Traditional Chinese Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Drug discovery relies on cellular assays to determine whether a candidate produces a desired response, reveals its mechanism, or causes toxicity, but only a small fraction of compound–dose–time–context combinations can be measured experimentally. Recent perturbation atlases, single-cell and imaging technologies, and intervention-conditioned AI models now make prediction of unmeasured cellular responses a testable objective. AI virtual cells could therefore complement conventional discovery by prioritizing compounds, contexts, and follow-up experiments rather than replacing laboratory assays. Here, we review the resources and modeling advances supporting this capability, assess their value for mechanism-of-action analysis, efficacy, safety, resistance, and combination studies, and define evidence requirements for pharmacological use. Data coverage makes oncology, including immuno-oncology, plausible early proving grounds, with safety assessment as a crosscutting use case; broader deployment requires perturbation-specific, mechanistic, and decision-level validation.

Original languageEnglish
Pages (from-to)1085-1098
Number of pages14
JournalTrends in Pharmacological Sciences
Volume47
Issue number10
DOIs
Publication statusPublished - Oct 2026

Keywords

  • AI virtual cells
  • drug discovery
  • perturbation biology
  • phenotypic profiling
  • single-cell modeling
  • virtual pharmacology

Fingerprint

Dive into the research topics of 'AI virtual cells for drug discovery and pharmacology'. Together they form a unique fingerprint.

Cite this